Evidence map›Paper›PMID 21658566›Full record

ArticleJournal of the American College of Cardiology2011

Sonic hedgehog-induced functional recovery after myocardial infarction is enhanced by AMD3100-mediated progenitor-cell mobilization.

Jérôme Roncalli, Marie-Ange Renault, Jörn Tongers, Sol Misener, Tina Thorne, Christine Kamide, Kentaro Jujo, Toshikazu Tanaka, Masaaki Ii, Ekaterina Klyachko and 1 more

Open access · greenAbstract read
In one paragraph

Article in Journal of the American College of Cardiology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 57 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Signaling pathways and targeted therapy for myocardial infarction.Signal transduction and targeted therapy · 2022
    Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Hh signaling in regeneration of the ischemic heart.Cellular and molecular life sciences : CMLS · 2017
    Review
  15. Circulating fibrocyte mobilization in negative pressure wound therapy.Journal of cellular and molecular medicine · 2017
    Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Hedgehog and Resident Vascular Stem Cell Fate.Stem cells international · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 4 countries.

Jérôme RoncalliFeinberg Cardiovascular Research Institute, Northwestern University, Chicago, Illinois 60611, USA.
Marie-Ange Renault
Jörn Tongers
Sol Misener
Tina Thorne
Christine Kamide
Kentaro Jujo
Toshikazu Tanaka
Masaaki Ii
Ekaterina Klyachko
Douglas W Losordo
Northwestern University · USFoundation for Biomedical Research and Innovation · JP

Funding

VEGF transfer to promote angiogenesis in advanced CHFP01HL066957 · NHLBI · CARITAS ST. ELIZABETH'S MEDICAL CENTER · PI HIRST, KATHRYN · 2001 to 2005
$8.7M
Therapeutic Angiogenesis in Vascular Medicine IVR01HL053354 · NHLBI · TEMPLE UNIV OF THE COMMONWEALTH · PI KISHORE, RAJ · 1995 to 2015
$4.2M
RE-ENDOTHELIALIZATION AND RESTENOSIS IIR01HL057516 · NHLBI · STEWARD ST. ELIZABETH'S MEDICAL CENTER · PI LOSORDO, DOUGLAS W · 1997 to 2008
$3.3M
Autologous CD34+ Cell Therapy for Therapeutic Angiogenesis in Advanced PADR01HL077428 · NHLBI · STEWARD ST. ELIZABETH'S MEDICAL CENTER · PI LOSORDO, DOUGLAS W · 2006 to 2011
$2.5M
Role of Progenitor Cells in Cardiovascular MedicineR01HL080137 · NHLBI · STEWARD ST. ELIZABETH'S MEDICAL CENTER · PI LOSORDO, DOUGLAS W · 2006 to 2010
$1.9M
Novel approaches to ischemic tissue repairR01HL095874 · NHLBI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI KISHORE, RAJ · 2009 to 2012
$1.5M
THERAPEUTIC ANGIOGENESIS IN VASCULAR MEDICINE IIR37HL053354 · NHLBI · CARITAS ST. ELIZABETH'S MEDICAL CENTER · PI ISNER, JEFFREY · 2000 to 2001
$726k
NHLBI NIH HHS HL-53354NHLBI NIH HHS HL-57516NHLBI NIH HHS HL-77428NHLBI NIH HHS HL-80137NHLBI NIH HHS HL-95874NHLBI NIH HHS P01 HL066957NHLBI NIH HHS P01HL-66957NHLBI NIH HHS R01 HL053354NHLBI NIH HHS R01 HL057516NHLBI NIH HHS R01 HL077428NHLBI NIH HHS R01 HL080137NHLBI NIH HHS R01 HL095874NHLBI NIH HHS R37 HL053354
6 · The paper itself

Abstract

objectivesThis study was designed to compare the effectiveness of Sonic hedgehog (Shh) gene transfer, AMD3100-induced progenitor-cell mobilization, and Shh-AMD3100 combination therapy for treatment of surgically induced myocardial infarction (MI) in mice.

backgroundShh gene transfer improves myocardial recovery by up-regulating angiogenic genes and enhancing the incorporation of bone marrow-derived progenitor cells (BMPCs) in infarcted myocardium. Here, we investigated whether the effectiveness of Shh gene therapy could be improved with AMD3100-induced progenitor-cell mobilization.

methodsGene expression and cell function were evaluated in cells cultured with medium collected from fibroblasts transfected with plasmids encoding human Shh (phShh). MI was induced in wild-type mice, in matrix metalloproteinase (MMP)-9 knockout mice, and in mice transplanted with bone marrow that expressed green-fluorescent protein. Mice were treated with 100 μg of phShh (administered intramyocardially), 5 mg/kg of AMD3100 (administered subcutaneously), or both; cardiac function was evaluated echocardiographically, and fibrosis, capillary density, and BMPC incorporation were evaluated immunohistochemically.

resultsphShh increased vascular endothelial growth factor and stromal cell-derived factor 1 expression in fibroblasts; the medium from phShh-transfected fibroblasts increased endothelial-cell migration and the migration, proliferation, and tube formation of BMPCs. Combination therapy enhanced cardiac functional recovery (i.e., left ventricular ejection fraction) in wild-type mice, but not in MMP-9 knockout mice, and was associated with less fibrosis, greater capillary density and smooth muscle-containing vessel density, and enhanced BMPC incorporation.

conclusionsCombination therapy consisting of intramyocardial Shh gene transfer and AMD3100-induced progenitor-cell mobilization improves cardiac functional recovery after MI and is superior to either individual treatment for promoting therapeutic neovascularization.

Indexed as

AnimalsBenzylaminesCell MovementCyclamsDisease Models, AnimalGenetic TherapyGene Transfer TechniquesHedgehog ProteinsHeterocyclic CompoundsHumansInjections, IntralesionalInjections, SubcutaneousMiceMice, KnockoutMyocardial InfarctionNeovascularization, PhysiologicBenzylaminesCyclamsHedgehog ProteinsHeterocyclic CompoundsplerixaforShh protein, mouse

Identifiers

PMID21658566
PMCPMC3117426
OpenAlexW2076730304

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.